RESMED INC — Director's Dealing 2019

Nov 23, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2019-11-21

Reporting Person: Farrell Michael J. (Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-11-21	ResMed Common Stock	A	117971	$146.34	Acquired	420502	Direct
2019-11-21	ResMed Common Stock	F	65802	$146.34	Disposed	354700	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-11-21	ResMed Common Stock Options	$146.34	A	59894	Acquired	2026-11-21	ResMed Common Stock (59894)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
ResMed Common Stock	10340	Indirect

Footnotes

F1: Represents performance-based restricted stock units granted on November 16, 2016. The shares were earned on November 21, 2019, when the compensation committee certified that the performance metrics were met.

F2: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/16/2016.

F3: Represents date options first become exercisable. Options vest 1/3 annually each November 11, 2020, 2021 and 2022.